Doctors Medicine Pharma Companies Research 
World of DTC Marketing
AUGUST 29, 2022
A sales representative for a biotech company shared information with oncologists about patients’ attitudes towards treatment options, including the company’s brand. The research showed that patients wanted to understand how the drug works and the potential side effects.
World of DTC Marketing
MARCH 11, 2022
But do doctors trust the system? healthcare system significantly declined during the pandemic , along with their confidence in the leaders and executives at the healthcare organizations employing them, according to a report from the nonpartisan research group NORC at the University of Chicago commissioned by the ABIM Foundation.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
World of DTC Marketing
AUGUST 10, 2021
SUMMARY : Falsehoods have been shown to spread faster and farther than accurate information, and research suggests that misinformation can have negative effects in the real world, such as amplifying controversy about vaccines and propagating unproven cancer treatments.
World of DTC Marketing
APRIL 7, 2021
Pharma, PBM, and health insurance CEOs earn hundreds of millions of dollars to do one thing; make their companies a lot of money. Government funding contributed to research associated with all 210 new drugs approved by the U.S. Rising costs are unsustainable despite the talk about virtual visits.
pharmaphorum
OCTOBER 11, 2022
So, historically – certainly pre-2000 – if you look at the way prescription drugs were communicated, it was very tightly controlled: it was pharma companies speaking to doctors and the doctor would speak to the patient and tell them what they thought the right solution was,” he said.
pharmaphorum
DECEMBER 15, 2021
For their parts, patient advocates share survey results with drug companies or recruit patients and caregivers to speak about the nature of their diseases and existing treatments. Second—and closely related to the first transformation—patient centricity requires new kinds of relationships between industry and patient advocacy groups.
Drug Discovery World
AUGUST 16, 2022
These observations may come to light in the clinic, but these disparities can be attributed to every phase of the drug development pipeline – clinical trials, translational research and, ultimately, drug discovery. . Representation disparities exist among researchers, clinicians, clinical trial investigators, and supporting staff.
Expert insights. Personalized for you.
203 
Let's personalize your content